Therapeutic Classes/Parenteral Iron Replacement

Parenteral Iron Replacement

10 drugs across 8 manufacturers|3 Generic,7 Brand

The Parenteral Iron Replacement class contains 10 NDCs from 8 manufacturers (3 generic, 7 brand), at an average NADAC of $9.27 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

10

3G / 7B

Manufacturers

8

Avg $9.2657/unit

Avg 7d Change

+0.21%

Across 2 drugs with changes

7d Activity

2↑8 flat

of 10 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Drug Portfolio

10 drugs total, 10 shown

Drug ↕Price 7d Change ↕
INFED 100 MG/2 ML VIAL
Iron Dextran
$18.8898
per ML
+0.07%
VENOFER 200 MG/10 ML VIAL
iron sucrose
$12.5305
per ML
—
VENOFER 100 MG/5 ML VIAL
iron sucrose
$12.2067
per ML
—
VENOFER 100 MG/5 ML VIAL
iron sucrose
$12.2067
per ML
—
VENOFER 100 MG/5 ML VIAL
iron sucrose
$12.2067
per ML
—
ACCRUFER 30 MG CAPSULE
Ferric Maltol
$10.0850
per EA
—
AURYXIA 210 MG TABLET
ferric citrate
$7.4809
per EA
—
FERRIC CITRATE 210 MG TABLET
Ferric Citrate
$6.2751
per EA
+0.34%
SE-TAN PLUS CAPSULE
MULTIVITAMIN/MINERAL
$0.3921
per EA
—
PUREVIT DUALFE PLUS CAPSULE
Ferrous Fumarate, Polysaccharide Iron Complex
$0.3839
per EA
—

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Frequently Asked Questions

How many drugs are in the Parenteral Iron Replacement class?

The Parenteral Iron Replacement class contains 10 NDCs from 8 manufacturers — 3 generic and 7 brand products.

What is the average price of Parenteral Iron Replacement drugs?

The average NADAC for the Parenteral Iron Replacement class is $9.2657 per unit across 10 NDCs.

Which manufacturers make Parenteral Iron Replacement drugs?

8 manufacturers make drugs in the Parenteral Iron Replacement class. Ranked by number of NDCs, the largest are American Regent, Inc. (3), Allergan, Inc. (1), Fresenius Medical Care Holdings, Inc. (1), Shield TX (UK) Ltd (1), Akebia Therapeutics, Inc. (1).

How has Parenteral Iron Replacement pricing changed recently?

Over the past 7 days, 2 NDCs in this class rose and 0 fell, with a class-wide average change of +0.2%.